CN112390859B - Self-assembly polypeptide probe for identifying Caspase protein, preparation method and application - Google Patents

Self-assembly polypeptide probe for identifying Caspase protein, preparation method and application Download PDF

Info

Publication number
CN112390859B
CN112390859B CN202011312853.0A CN202011312853A CN112390859B CN 112390859 B CN112390859 B CN 112390859B CN 202011312853 A CN202011312853 A CN 202011312853A CN 112390859 B CN112390859 B CN 112390859B
Authority
CN
China
Prior art keywords
afc
caspase
fmoc
nap
gff
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202011312853.0A
Other languages
Chinese (zh)
Other versions
CN112390859A (en
Inventor
张智松
李鲁远
张立松
夏莹
毕建鹏
杨雨萌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nankai University
Original Assignee
Nankai University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nankai University filed Critical Nankai University
Priority to CN202011312853.0A priority Critical patent/CN112390859B/en
Publication of CN112390859A publication Critical patent/CN112390859A/en
Application granted granted Critical
Publication of CN112390859B publication Critical patent/CN112390859B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22Cysteine endopeptidases (3.4.22)
    • C12Y304/22056Caspase-3 (3.4.22.56)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22Cysteine endopeptidases (3.4.22)
    • C12Y304/22061Caspase-8 (3.4.22.61)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention relates to a self-assembly polypeptide probe for identifying Caspase protein, a preparation method and application thereof, and a prepared small molecular polypeptide compound Nap-GFFPYDEVD-AFC and Nap-GFFPYIETD-AFC, using small-molecule polypeptide Nap-GFFPY is connected with recognition sequences DEVD and IETD of Caspase-3 and Caspase-8 proteins and a fluorophore AFC, the small molecular polypeptide compound is catalyzed by alkaline phosphatase to self-assemble to form nano hydrogel, the nano hydrogel can enter cells in an endocytosis mode, and the recognition sequences DEVD and IETD matched with the Caspase-3 and Caspase-8 proteins can be used for indicating the activity of the Caspase-3 and Caspase-8 proteins in the cells. Therefore, the nano hydrogel transmission system established by the invention not only solves the problems of low solubility and low cell entering efficiency of Ac-DEVD-AFC and Ac-IETD-AFC, but also can indicate the expression conditions of Caspase-3 and Caspase-8 proteins in apoptotic cells by using AFC.

Description

Self-assembly polypeptide probe for identifying Caspase protein, preparation method and application
Technical Field
The invention belongs to the field of biomedicine, and particularly relates to a self-assembly polypeptide probe for identifying Caspase protein, a preparation method and application thereof.
Background
Apoptosis, also known as programmed cell death, is a self-destruction mechanism that exists in cells. During apoptosis, caspases, play an important roleIn use, the process of apoptosis is actually a cascade of amplification reactions in which Caspase irreversibly hydrolyzes substrates. Caspase-3 and Caspase-8 play a very important role in the Caspase family. The current method for detecting the apoptosis proteins Caspase-3 and Caspase-8 is mainly realized by specific recognition sequences DEVD and IETD of Caspase-3 and Caspase-8. Ac-DEVD (IETD) -AFC is a commonly used detection method, but because of the problems of poor solubility and low efficiency of entering cells, the expression conditions of Caspase-3 and Caspase-8 proteins cannot be detected in real time in living cells according to fluorescence intensity. Rapid detection of the apoptotic proteins Caspase-3 and Caspase-8 in living cells undergoing apoptosis is a significant challenge. The living cell labeling technology requires high specificity, high labeling density, cell permeability of labeled molecules, and strong targeting of target proteins. To develop a simpler and more convenient platform, we take advantage of the self-assembly properties of small molecule polypeptides. Because of its advantages of good biocompatibility, no toxicity to human body, easy synthesis, etc. Small molecule hydrogel as a novel material has been widely studied by scientists at home and abroad due to good biocompatibility and good three-dimensional appearance in the aspects of biomedicine and biomaterials. To date, the connection of Nap-GFF to the N-terminal of small-molecule polypeptide has not been foundPDEVD (IETD) -AFC is connected with the Y end and the C end, nanofibers are formed through alkaline phosphatase catalysis self-assembly, and research reports of the expression conditions of Caspase-3 and Caspase-8 proteins in apoptotic cells can be indicated in real time.
Disclosure of Invention
The invention aims to solve the problems in the prior art and aims to solve the problems by using short peptide Nap-GFFPY, Caspase-3/8 specific recognition sequence DEVD/IETD and AFC are connected to form Nap-GFFPYDEVD-AFC and Nap-GFFPThe micromolecular polypeptide compound of YIETD-AFC forms nano-fiber through alkaline phosphatase catalysis self-assembly, the nano-fiber can enter cells in an endocytosis mode, and the protein activities of Caspase-3 and Caspase-8 in the living cells which are subjected to apoptosis are detected according to the fluorescence intensity of AFC.
The self-assembly polypeptide probe for recognizing Caspase protein is used for recognizing Caspase-3Self-assembly polypeptide probe Nap-GFF of proteinPThe structural formula of YDEVD-R is as follows:
Figure GDA0002892479620000021
self-assembly polypeptide probe Nap-GFF for recognizing Caspase-8 proteinPThe structural formula of YIETD-R is as follows:
Figure GDA0002892479620000022
wherein R is a fluorescent functional group;
Figure GDA0002892479620000023
wherein the content of the first and second substances,
Figure GDA0002892479620000024
wherein-Nap represents a naphthylacetic acid hydrophobic end-capping group, -AFC represents a fluorophore formed by an aspartic acid derivative. Self-assembled short peptide Nap-GFFPThe connection of Y with DEVD-AFC and IETD-AFC may be selected from 0 to 3 glycines.
The invention also provides a preparation method of the self-assembly polypeptide probe for recognizing Caspase protein, which is characterized by mainly comprising the following steps:
(1) the intermediate compound Fmoc-Asp (OH) -AFC was synthesized as follows:
i) taking Fmoc-Asp (OtBu) -COOH, coumarin 151, anhydrous pyridine and phosphorus oxychloride for reaction; after reaction, adding a hydrochloric acid solution, extracting and drying to obtain Fmoc-Asp (OtBu) -AFC;
ii) dissolving Fmoc-Asp (OtBu) -AFC in trifluoroacetic acid solution, and reacting under ice bath condition to obtain Fmoc-Asp (OH) -AFC;
(2)Nap-GFFPYDEVD-AFC and Nap-GFFPThe synthesis process of YIETD-AFC is as follows:
iii) connecting Fmoc-Asp (OH) -AFC synthesized in (1) to a solid-phase carrier 2-chlorotrityl chloride resin in a solid-phase synthesizer, and reacting for 1-3 hours by using dichloromethane as a solvent;
iv) removing a protecting group Fmoc by using a dimethyl formamide solution of piperidine, taking a polypeptide condensing agent HBTU, putting the polypeptide condensing agent HBTU into the solid phase synthesizer in the step iii), sequentially adding Fmoc-valine, Fmoc-glutamic acid, Fmoc-aspartic acid, Fmoc-phosphotyrosine, Fmoc-phenylalanine and Fmoc-glycine for reaction, and blocking the N end of the polypeptide by using naphthylacetic acid to obtain the Nap-GFFPYDEVD-AFC; sequentially adding Fmoc-threonine, Fmoc-glutamic acid, Fmoc-isoleucine, Fmoc-phosphotyrosine, Fmoc-phenylalanine and Fmoc-glycine for reaction, and capping the N end of the polypeptide by using naphthylacetic acid to obtain the Nap-GFFPYIETD-AFC。
v) cleaving the prepared self-assembled short peptide probe from the solid phase resin with 95% trifluoroacetic acid, and HPLC-cleaving the resulting Nap-GFFPYDEVD-AFC and Nap-GFFPAnd purifying and separating YIETD-AFC.
The invention also provides a method for applying the self-assembly polypeptide probe for identifying Caspase protein to a small molecule hydrogel nanofiber transmission system, and Nap-GFFPThe YDEVD-AFC micromolecule compound is self-assembled to form nano-fibers under the action of alkaline phosphatase on the surface of a cell membrane, and the nano-fibers enter cells in an endocytosis mode; is recognized by Caspase-3 protein in apoptotic cells and is cut to release a fluorescent group AFC, thus playing a role in detecting the expression of Caspase-3 protein in live cells in real time;
Nap-GFFPunder the action of alkaline phosphatase on the surface of a cell membrane, a YIETD-AFC small molecular compound self-assembles to form a nanofiber and enters cells in an endocytosis mode; is recognized by Caspase-8 protein in apoptotic cell and cut to release fluorescent group AFC, which plays the role of real-time detection of Caspase-8 protein expression in living cell.
It should be noted that all amino acids used in the present invention are natural amino acids in L configuration.
The invention has the following beneficial effects:
(1) the small molecular self-assembly polypeptide compound Nap-GFF prepared by the inventionPYDEVD-AFC and Nap-GFFPYIETD-AFC, using small-molecule polypeptide Nap-GFFPY is connected with recognition sequences DEVD and IETD of Caspase-3 and Caspase-8 proteins and a fluorophore AFC, the small molecular polypeptide compound is catalyzed by alkaline phosphatase to self-assemble to form nano hydrogel (nanofiber), the nano hydrogel can enter cells in an endocytosis mode, and the recognition sequences DEVD and IETD matched with the Caspase-3 and Caspase-8 proteins can be used for indicating the activity of the Caspase-3 and Caspase-8 proteins in the cells; namely, the problem of solubility of Ac-DEVD (IETD) -AFC is solved. The expression of Caspase-3(Caspase-8) protein in apoptotic cells can also be detected in real time in living cells.
(2) The small molecular polypeptide compound Nap-GFF of the inventionPYDEVD-AFC and Nap-GFFPRaw materials used in the YIETD-AFC preparation process are various amino acids required by cultured cells every day, no toxic or side effect is generated on the cells, and the prepared Nap-GFFPYDEVD-AFC and Nap-GFFPThe MTT results of YIETD-AFC showed no inhibition of cell growth.
(3) The nano hydrogel prepared by the invention has good biocompatibility and good three-dimensional appearance (about 10nm nano-fiber), can more easily enter tumor cells, and can be widely applied to Caspase-3/8 activity detection.
Drawings
FIG. 1 is a scheme showing the chemical synthesis scheme of Fmoc-L-Asp (OtBu) -AFC;
FIG. 2 shows Nap-GFFPYDEVD-AFC and Nap-GFFPChemical synthesis scheme of YIETD-AFC;
FIG. 3 shows Nap-GFFPA hydrogen spectrum of YDEVD-AFC;
FIG. 4 shows Nap-GFFPHydrogen spectrum of YIETD-AFC;
FIG. 5 shows Nap-GFFPYDEVD-AFC and Nap-GFFPA three-dimensional topography observed by a transmission electron microscope of YIETD-AFC two kinds of small molecular hydrogel, wherein ALP is serum alkaline phosphatase;
FIG. 6 shows the protein Caspase-3 vs. Nap-GFFPYDEVD-AFC probesInfluence of medium AFC fluorophore release;
FIG. 7 shows the protein Caspase-8 vs. Nap-GFFPEffect of AFC fluorophore release in YIETD-AFC probe;
FIG. 8 shows Nap-GFF in Hela cellsPThe concentration of YDEVD-AFC is 50 mu mol/L, and the concentration is 1mmol/L H2O2Induces Hela cells to undergo apoptosis at the concentration of (a); the fluorescence intensity of AFC is gradually increased along with the increase of induction time (0min, 10min, 20min, 40min and 60 min);
FIG. 9 shows Nap-GFF in Hela cellsPThe concentration of YDEVD-AFC is 50 mu mol/L, and the concentration is 1mmol/L H2O2Induces Hela cells to undergo apoptosis at the concentration of (a); the fluorescence intensity of AFC was gradually increased with the increase of the induction time (0min, 10min, 20min, 40min, 60 min).
Detailed Description
Unless defined otherwise, technical terms used in the following examples have the same meanings as commonly understood by one of ordinary skill in the art to which the present invention belongs. The test reagents used in the following examples, unless otherwise specified, are all conventional biochemical reagents; the experimental methods are conventional methods unless otherwise specified. The present invention will be described in detail with reference to examples.
EXAMPLE Synthesis of Fmoc-L-Asp (OH) -AFC
Fmoc-L-Asp (OtBu) -OH (10mmol, 4.11 g) and 7-amino-4-trifluoromethylcoumarin (10mmol, 2.29 g) were weighed into a 50 mL round-bottomed flask, 40 mL of anhydrous pyridine was added, and 10mmol of phosphorus oxychloride (3.06g) was added dropwise at minus 15 ℃. And (4) protecting the reaction product with nitrogen so as to avoid contacting moisture in the air, and reacting for 30 minutes at a constant temperature of minus 15 ℃. To the dark red viscous liquid was added 3mol/L hydrochloric acid solution until the PH of the solution was 2. Extracted three times with ethyl acetate, washed three times with saturated brine, and dried over anhydrous sodium sulfate for 2 hours. Ethyl acetate was removed by rotary evaporation. Purification by silica gel chromatography (ethyl acetate: petroleum ether ═ 1: 3). A total of 5.07 g of Fmoc-L-Asp (OtBu) -AFC was obtained as a white solid in 81.38% yield.
Fmoc-L-Asp (OtBu) -AFC (6.42mmol, 4g) was weighed out and dissolved in a solution of 95% trifluoroacetic acid (trifluoroacetic acid: dichloromethane 95%: 5%) and reacted for 60 minutes under ice-bath conditions. Trifluoroacetic acid and dichloromethane were removed by rotary evaporation and purified by silica gel chromatography (dichloromethane: methanol 75: 1) to give a total of 2.59 g of Fmoc-L-asp (oh) -AFC in 71.26% yield.
The synthesis steps of this example can be referred to in FIG. 1.
EXAMPLE DINap-GFFPYDEVD-AFC and Nap-GFFPChemical Synthesis of YIETD-AFC
Synthesis of Nap-GFF by solid phase synthesis methodPYDEVD-AFC and Nap-GFFPThe YIETD-AFC comprises the following specific synthetic steps:
(1) 0.75mmol (700 mg) of the dichloro resin was weighed into a solid phase synthesizer, 20 ml of Dichloromethane (DCM) was added to immerse the resin, the resin was swollen for 20 minutes, DCM solvent was removed, 1mmol (566 mg) of Fmoc-L-Asp (OH) -AFC in DCM was added, and 800. mu.l of N, N-Diisopropylethylamine (DIPEA) was added. The reaction was carried out for 2 hours. After which it was washed five times with DCM for 2 minutes each. Using volume ratio DCM: methanol: DIPEA ═ 17: 2: 1 for 30 minutes. After that, the column was washed 5 times with 20 ml portions of DCM solution each time for 1 minute. After which the column was washed 5 times with 20 ml portions of DMF solution each time for 2 minutes.
(2) Nap-GFF was prepared on the basis of addition of 20 ml of 20% piperidine in DMF, reaction for 30 minutes, removal of Fmoc protecting group and exposure of amino group for the next reactionPYDEVD-AFC and Nap-GFFPYIETD-AFC。
Nap-GFFPThe preparation process of YDEVD-AFC is as follows: to the solid phase synthesis tube, 1mmol of peptide condensing agent HBTU (379 mg), 1mmol of Fmoc-valine (339 mg) were added and reacted for 120 minutes. The Fmoc group was then cleaved with 20% piperidine for 30 min, washed 5 times with 20 mL Dimethylformamide (DMF) solution for 2 min each. Thereafter, 1mmol of peptide condensing agent HBTU (379 mg), 1mmol of Fmoc-glutamic acid (426 mg) were added thereto, respectively, and the reaction was carried out for 120 minutes. The Fmoc group was then cleaved with 20% piperidine for 30 min and washed 5 times with 20 mL of DMF for 2 min each. Thereafter, 1mmol of peptide condensing agent HBTU (379 mg), 1mmol of Fmoc-aspartic acid (412 mg) were added thereto, and the reaction was carried out for 120 minutesA clock. The Fmoc group was then cleaved with 20% piperidine for 30 min and washed 5 times with 20 mL of DMF for 2 min each. Thereafter, 1mmol of peptide condensing agent HBTU (379 mg), 1mmol of Fmoc-phosphotyrosine (484 mg) were added, respectively, and reacted for 120 minutes. The Fmoc group was then cleaved with 20% piperidine for 30 min and washed 5 times with 20 mL of DMF for 2 min each. Thereafter, 1mmol of peptide condensing agent HBTU (379 mg) and 1mmol of Fmoc-phenylalanine (388 mg) were added, respectively, and the reaction was carried out for 120 minutes. The Fmoc group was then cleaved with 20% piperidine for 30 min and washed 5 times with 20 mL of DMF for 2 min each. Fmoc-phenylalanine was added in duplicate and the reaction was carried out for 120 minutes. Thereafter, 1mmol of peptide condensing agent HBTU (379 mg), 1mmol of Fmoc-glycine (297 mg) were added thereto, and the reaction was carried out for 120 minutes. The Fmoc group was then cleaved with 20% piperidine for 30 min and washed 5 times with 20 mL of DMF for 2 min each. Thereafter, 1mmol of peptide condensing agent HBTU (379 mg) and 1mmol of naphthylacetic acid (186 mg) were added thereto, respectively, and the reaction was carried out for 120 minutes. After the reaction was complete, the reaction mixture was washed 5 times with 20 ml of DMF solution for 2 minutes each. The reaction mixture was washed 5 times with 20 ml of DCM solution each time for 1 minute. With 95% trifluoroacetic acid (TFA) (TFA: H)2O: TIS 95%: 2.5%: 2.5%) for 1 hour to obtain Nap-GFFPYDEVD-AFC。
Nap-GFFPThe YIETD-AFC is prepared as follows: 1mmol of peptide condensing agent HBTU (379 mg) and 1mmol of Fmoc-threonine (339 mg) were added to a solid phase synthesis tube and reacted for 120 minutes. The Fmoc group was then cleaved with 20% piperidine for 30 min, washed 5 times with 20 mL Dimethylformamide (DMF) solution for 2 min each. Thereafter, 1mmol of peptide condensing agent HBTU (379 mg), 1mmol of Fmoc-glutamic acid (426 mg) were added thereto, respectively, and the reaction was carried out for 120 minutes. The Fmoc group was then cleaved with 20% piperidine for 30 min and washed 5 times with 20 mL of DMF for 2 min each. Thereafter, 1mmol of peptide condensing agent HBTU (379 mg), 1mmol of Fmoc-isoleucine (354 mg) were added, respectively, and reacted for 120 minutes. The Fmoc group was then cleaved with 20% piperidine for 30 min and washed 5 times with 20 mL of DMF for 2 min each. Thereafter, 1mmol of peptide condensing agent HBTU (379 mg), 1mmol of Fmoc-phosphotyrosine (484 mg) were added, respectively, and reacted for 120 minutes. Then 20 percent of the total weight is usedThe Fmoc group was cleaved with piperidine for 30 min, washed 5 times with 20 mL of DMF for 2 min each. Thereafter, 1mmol of peptide condensing agent HBTU (379 mg) and 1mmol of Fmoc-phenylalanine (388 mg) were added, respectively, and the reaction was carried out for 120 minutes. The Fmoc group was then cleaved with 20% piperidine for 30 min and washed 5 times with 20 mL of DMF for 2 min each. Fmoc-phenylalanine was added in duplicate and the reaction was carried out for 120 minutes. Thereafter, 1mmol of peptide condensing agent HBTU (379 mg), 1mmol of Fmoc-glycine (297 mg) were added thereto, and the reaction was carried out for 120 minutes. The Fmoc group was then cleaved with 20% piperidine for 30 min and washed 5 times with 20 mL of DMF for 2 min each. Thereafter, 1mmol of peptide condensing agent HBTU (379 mg) and 1mmol of naphthylacetic acid (186 mg) were added thereto, respectively, and the reaction was carried out for 120 minutes. After the reaction was complete, the reaction mixture was washed 5 times with 20 ml of DMF solution for 2 minutes each. The reaction mixture was washed 5 times with 20 ml of DCM solution each time for 1 minute. With 95% trifluoroacetic acid (TFA) (TFA: H)2O: TIS 95%: 2.5%: 2.5%) for 1 hour to obtain Nap-GFFPYIETD-AFC。
(3) Washing with 1% TFA in dichloromethane 20 ml twice, collecting total cleavage solution, removing liquid by rotary evaporation, and separating polypeptide compound Nap-GFF with high performance liquid phasePYDEVD-AFC and Nap-GFFPYIETD-AFC separation;
in this step, the process of high performance liquid chromatography separation is as follows: passing through a C-18 reversed phase chromatographic column, and performing gradient elution by using water and methanol as eluent and 30-80% of methanol for 25 minutes; performing preparative HPLC on the eluent, and collecting fractions with retention time tR of 15.0-15.5 min to obtain Nap-GFFPYDEVD-AFC; collecting the flow with retention time tR of 13.6-14.3 min under the same condition to obtain Nap-GFFPYIETD-AFC。
The synthesis steps of this embodiment can be referred to fig. 2;
Nap-GFFPYDEVD-AFC and Nap-GFFPThe mass spectra of YIETD-AFC are shown in FIG. 3 and FIG. 4, respectively.
EXAMPLE three Small molecule hydrogel Nap-GFFPYDEVD-AFC and Nap-GFFPFormation of YIETD-AFC
The formation steps of the small molecule hydrogel are as follows:
(1) balance2.00mg of the obtained polypeptide compound was added to 1ml of PBS (pH 7.4 buffer), and the pH was adjusted to 7.4 with sodium carbonate to form a probe solution. Adding alkaline phosphatase solution (final concentration of enzyme is 2.0U/ml), standing overnight, and turning upside down to obtain Nap-GFFPYDEVD-AFC and Nap-GFFPYIETD-AFC gel-like substance.
(2) Sucking about 15 microliters of colloid by using a pipette gun, dropwise adding the colloid on a silicon wafer with a clean surface, spin-coating to ensure that the colloid is uniformly distributed on the silicon wafer, and observing the appearance by using a transmission electron microscope, wherein the specific figure is 5; the appearance of the nano-fiber is about 10nm of nano-fiber which is uniformly dispersed.
Example tetrapase-3 and Caspase-8 proteins promote the probe Nap-GFF, respectivelyPYDEVD-AFC and Nap-GFFPRelease of fluorophore AFC from YIETD-AFC.
(1) Taking Nap-GFF with initial concentration of 10mmol/L P500. mu.l of a mother solution of YDEVD-AFC was prepared in the form of probe solutions having concentrations of 80. mu. mol/L, 40. mu. mol/L, 20. mu. mol/L, 10. mu. mol/L and 5. mu. mol/L. Caspase-3 protein is added at 25 deg.c and the mixture is set for 2 hr. The fluorescence intensity of AFC in the solution was then measured with a fluorescence photometer. See in particular fig. 6; the fluorescence intensity of the fluorescent probe is dependent on Nap-GFFPThe increase in the concentration of YDEVD-AFC was gradually increased.
(2) Taking Nap-GFF with initial concentration of 10mmol/LPThe mother solution of YIETD-AFC was prepared in 500. mu.l of probe solutions having concentrations of 80. mu. mol/L, 40. mu. mol/L, 20. mu. mol/L, 10. mu. mol/L and 5. mu. mol/L. Caspase-8 protein is added at 25 deg.c and the mixture is set for 2 hr. The fluorescence intensity of AFC in the solution was then measured with a fluorescence photometer. See in particular fig. 7; the fluorescence intensity of the fluorescent probe is dependent on Nap-GFFPThe increase in YIETD-AFC concentration was gradually increased.
Example PenNap-GFFPYDEVD-AFC and Nap-GFFPBiological application of YIETD-AFC
(1) Normal culturing human cervical carcinoma Hela cell, uniformly spreading into 10 confocal small dishes, the cell number is 2.0x 104And (4) respectively. Culturing at 37 deg.C under 5% carbon dioxide for 8 hr, and adding Nap-GFFPYDEVD-AFC andNap-GFFPYIETD-AFC, concentration set at 50 μmol/L. Cultured for four hours to allow Nap-GFFPYDEVD-AFC and Nap-GFFPYIETD-AFC entered the cells. Then at a concentration of 1mmol/L H2O2Under the action of the probe, setting time gradient (0min, 10min, 20min, 40min and 60min) to induce Hela cells to generate apoptosis, and shooting the fluorescence intensity of each group of cells by using a confocal microscope to further reflect the expression quantity of Caspase-3 and Caspase-8 proteins in the apoptotic cells. The results show that: with H2O2The induction time is prolonged, the expression quantity of the apoptotic proteins Caspase-3 and Caspase-8 is gradually increased, the quantity of AFC released by cutting is also gradually increased, the fluorescence intensity displayed by AFC is also gradually enhanced, and the result is shown in figures 8 and 9, which shows that the self-contained polypeptide probe designed by the invention can detect the apoptosis condition of cells in real time in living cells.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.

Claims (4)

1. The self-assembly polypeptide probe for identifying Caspase protein is characterized in that the Caspase protein is Caspase-3 protein and Caspase-8 protein;
self-assembly polypeptide probe Nap-GFF for recognizing Caspase-3 proteinPThe structural formula of YDEVD-AFC is as follows:
Figure FDA0003507729870000011
self-assembly polypeptide probe Nap-GFF for recognizing Caspase-8 proteinPThe structural formula of YIETD-AFC is as follows:
Figure FDA0003507729870000012
wherein-Nap ═
Figure FDA0003507729870000013
2. The method for preparing the self-assembly polypeptide probe for recognizing Caspase protein according to claim 1, which is characterized by mainly comprising the following steps:
(1) the intermediate compound Fmoc-Asp (OH) -AFC was synthesized as follows:
i) taking Fmoc-Asp (OtBu) -COOH and coumarin 151, adding anhydrous pyridine, and dropwise adding phosphorus oxychloride to react at the temperature of minus 15 ℃; after reaction, adding a hydrochloric acid solution, extracting and drying to obtain Fmoc-Asp (OTBu) -AFC;
ii) dissolving Fmoc-Asp (OtBu) -AFC in trifluoroacetic acid solution, and reacting under ice bath condition to obtain Fmoc-Asp (OH) -AFC;
(2)Nap-GFFPYDEVD-AFC and Nap-GFFPThe synthesis process of YIETD-AFC is as follows:
iii) connecting Fmoc-Asp (OH) -AFC synthesized in (1) to a solid-phase carrier 2-chlorotrityl chloride resin in a solid-phase synthesizer, and reacting for 1-3 hours by using dichloromethane as a solvent;
iv) removing a protecting group Fmoc by using a dimethyl formamide solution of piperidine, putting a polypeptide condensing agent HBTU into the solid phase synthesizer in the step iii), sequentially adding Fmoc-valine, Fmoc-glutamic acid, Fmoc-aspartic acid, Fmoc-phosphotyrosine, Fmoc-phenylalanine and Fmoc-glycine for reaction, and blocking the N end of the polypeptide by using naphthylacetic acid to obtain Nap-GFFPYDEVD-AFC; sequentially adding Fmoc-threonine, Fmoc-glutamic acid, Fmoc-isoleucine, Fmoc-phosphotyrosine, Fmoc-phenylalanine and Fmoc-glycine, and blocking the N end of the polypeptide by using naphthylacetic acid to obtain Nap-GFFPYIETD-AFC;
v) cleaving the prepared short peptide from the resin with trifluoroacetic acid, and subjecting the resulting Nap-GFFPYDEVD-AFC and Nap-GFFPYIETD-AFC were separated separately.
3. The self-assembled polypeptide probe capable of recognizing Caspase protein according to claim 1The application of the nano-fiber transmission system for preparing the micromolecular hydrogel is characterized in that the nano-fiber transmission system is Nap-GFFPThe YDEVD-AFC micromolecule compound is self-assembled to form nano-fibers under the action of alkaline phosphatase on the surface of a cell membrane, and the nano-fibers enter cells in an endocytosis mode; is recognized by Caspase-3 protein in apoptotic cell and cut to release fluorescent group AFC, which plays the role of real-time detection of Caspase-3 protein expression in living cell.
4. The application of the self-assembly polypeptide probe for recognizing Caspase protein in preparation of small molecule hydrogel nanofiber transmission system as claimed in claim 1, wherein the Nap-GFFPUnder the action of alkaline phosphatase on the surface of a cell membrane, a YIETD-AFC small molecular compound self-assembles to form a nanofiber and enters cells in an endocytosis mode; is recognized by Caspase-8 protein in apoptotic cell and cut to release fluorescent group AFC, which plays the role of real-time detection of Caspase-8 protein expression in living cell.
CN202011312853.0A 2020-11-20 2020-11-20 Self-assembly polypeptide probe for identifying Caspase protein, preparation method and application Active CN112390859B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011312853.0A CN112390859B (en) 2020-11-20 2020-11-20 Self-assembly polypeptide probe for identifying Caspase protein, preparation method and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011312853.0A CN112390859B (en) 2020-11-20 2020-11-20 Self-assembly polypeptide probe for identifying Caspase protein, preparation method and application

Publications (2)

Publication Number Publication Date
CN112390859A CN112390859A (en) 2021-02-23
CN112390859B true CN112390859B (en) 2022-04-05

Family

ID=74606021

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011312853.0A Active CN112390859B (en) 2020-11-20 2020-11-20 Self-assembly polypeptide probe for identifying Caspase protein, preparation method and application

Country Status (1)

Country Link
CN (1) CN112390859B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105497891A (en) * 2015-12-23 2016-04-20 南开大学 Application of polypeptide hydrogel serving as protein vaccine adjuvant and protein vaccine
CN106039325A (en) * 2011-09-01 2016-10-26 香港科技大学 fluorescent bioprobes and imaging method
CN111892720A (en) * 2020-07-29 2020-11-06 苏州大学 Method for inducing gelation and biomimetic mineralization of fibroin solution by alkaline phosphatase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19820328A1 (en) * 1998-05-07 1999-11-11 Roche Diagnostics Gmbh Method and reagent for the detection of apoptotic cells or a protease activated during apoptosis
CN102958938B (en) * 2011-05-24 2014-08-27 戴立军 Enzyme-degradable polymer and application thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106039325A (en) * 2011-09-01 2016-10-26 香港科技大学 fluorescent bioprobes and imaging method
CN105497891A (en) * 2015-12-23 2016-04-20 南开大学 Application of polypeptide hydrogel serving as protein vaccine adjuvant and protein vaccine
CN111892720A (en) * 2020-07-29 2020-11-06 苏州大学 Method for inducing gelation and biomimetic mineralization of fibroin solution by alkaline phosphatase

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Strain-Promoted Alkyne Azide Cycloaddition for the Functionalization of Poly(amide)-Based Dendrons and Dendrimers;Ca´tia Ornelas等;《J.Am.Chem.Soc.》;20100225;第132卷(第11期);全文 *
Synthesis, enzymatic evaluation, and docking studies of fluorogenic caspase 8 tetrapeptide substrates;Przemyslaw Reszka等;《ChemMedChem.》;20101031;第5卷(第1期);全文 *

Also Published As

Publication number Publication date
CN112390859A (en) 2021-02-23

Similar Documents

Publication Publication Date Title
CN112245593B (en) Stabilized cell penetrating peptide with hydrophobic side chain, preparation method and application
CN107266562B (en) Collagen polypeptide probe for specifically recognizing collagen and preparation and imaging methods thereof
CN108659099B (en) Mass spectrum probe for detecting activity of angiotensin converting enzyme and application thereof
CN106699846B (en) Anti-obesity undecapeptide NALKCCHSCPA
Loidl et al. Synthesis of β‐(1‐azulenyl)‐l‐alanine as a potential blue‐colored fluorescent tryptophan analog and its use in peptide synthesis
CN112794917B (en) Polypeptide imaging probe and preparation method and application thereof
CN103265620B (en) Somatostatin and preparation method thereof
CN106749524B (en) Anti-obesity heptapeptide NPVWKRK
CN112390859B (en) Self-assembly polypeptide probe for identifying Caspase protein, preparation method and application
CN103897029B (en) A kind of preparation method of romidepsin
CN111548419B (en) DDR2 targeting polypeptide and application thereof
CN110804087B (en) Integrin alpha v beta 3 targeted AIE fluorescent compound and preparation and application thereof
CN102199195B (en) Half-path charge matching amphiphilic self assembling short peptide, and application thereof as nanometer hemostatic material and hydrophobic drug carrier
CN107703109A (en) Two-dimentional molybdenum sulfide polypeptide composite and its application in CD47 cancer markers are targetted
CN114671912B (en) Method for homogeneously synthesizing blue copper tripeptide with assistance of light shearing carrier
CN111690039B (en) Self-assembly polypeptide probe for identifying 6xHis tag protein, preparation method and application
CN113616807B (en) Mitochondrion-targeted polypeptide and preparation method and application thereof
CN115286687A (en) Intracellular self-assembly degradation agent based on bioorthogonal reaction and preparation method and application thereof
US7371728B2 (en) Prostate-specific antigen probes for optical imaging
CN113429461A (en) Aggregation-induced emission polypeptide micelle type diagnostic reagent and application thereof in near-infrared region biological imaging
CN106749533B (en) Anti-obesity heptadecapeptide LNNPSVCDCDCMMKAAR
Rocchi et al. Synthesis of peptide analogs of the N-terminal eicosapeptide sequence of ribonuclease A. XI. Synthesis and conformational studies of [Orn10, Nle13]-S-peptide
CN112480212A (en) High-affinity peptide of targeted hepatocyte growth factor and application thereof
CN115317622A (en) Preparation and application of anti-tumor polypeptide coupled drug
CN116813704B (en) Tumor targeting fluorescent molecular probe and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant